Revolution Medicines stock surges over 20% on potential AbbVie acquisition

Go back to Revolution Medicines stock surges over 20% on potential AbbVie acquisition
AbbVie (NYSE: ABBV) Delayed: 224.94 +7.81 (3.60%)
Previous Close $217.13    52 Week High $68.12 
Open $222.50    52 Week Low $50.71 
Day High $224.99    P/E 48.79 
Day Low $219.84    EPS $4.61 
Volume 6,786,237       

(NASDAQ: ERAS) Delayed: 13.27 +0.09 (0.68%)
Previous Close $13.18    52 Week High
Open $13.53    52 Week Low
Day High $13.99    P/E N/A 
Day Low $13.01    EPS
Volume 7,958,320       

(NASDAQ: RVMD) Delayed: 155.69 -0.3 (0.19%)
Previous Close $155.99    52 Week High
Open $156.27    52 Week Low
Day High $159.34    P/E N/A 
Day Low $154.60    EPS
Volume 2,609,015       

(NASDAQ: TNGX) Delayed: 22.15 +0.68 (3.17%)
Previous Close $21.47    52 Week High
Open $21.47    52 Week Low
Day High $22.80    P/E N/A 
Day Low $21.47    EPS
Volume 1,247,587       

VERASTEM SHS (NASDAQ: VSTM) Delayed: 3.86 +0.24 (6.63%)
Previous Close $3.62    52 Week High $2.43 
Open $3.76    52 Week Low $1.05 
Day High $4.11    P/E N/A 
Day Low $3.73    EPS $-1.79 
Volume 3,535,789